Aggregated α‐synuclein activates microglia: a process leading to disease progression in Parkinson's disease

Cited by (1,000)

Items 501–600 of 1,000

1. Microglia as therapeutic target in central nervous system disorders
   Oluwaseun Fatoba, Takahide Itokazu, Toshihide Yamashita · 2020 · Journal of Pharmacological Sciences
2. Microglial Extracellular Vesicles as Vehicles for Neurodegeneration Spreading
   Inês Dinis Aires, Teresa Ribeiro‐Rodrigues, Raquel Boia, Magda Ferreira-Rodrigues, Henrique Girão, António Francisco Ambrósio, Ana Raquel Santiago · 2021 · Biomolecules
3. Elucidating the Neuroprotective Role of PPARs in Parkinson’s Disease: A Neoteric and Prospective Target
   Tapan Behl, Piyush Madaan, Aayush Sehgal, Sukhbir Singh, Neelam Sharma, Saurabh Bhatia, Ahmed Al‐Harrasi, Sridevi Chigurupati, Ibrahim Alrashdi, SIMONA GABRIELA BUNGAU · 2021 · International Journal of Molecular Sciences
4. Genistein: A focus on several neurodegenerative diseases
   Rongzi Li, Megan Robinson, Xiao-Wen Ding, Thangiah Geetha, Layla Al‐Nakkash, Tom L. Broderick, Jeganathan Ramesh Babu · 2022 · Journal of Food Biochemistry
5. Fractalkine Signaling in Microglia Contributes to Ectopic Orofacial Pain following Trapezius Muscle Inflammation
   Masaaki Kiyomoto, Masamichi Shinoda, Akiko Okada‐Ogawa, Noboru Noma, Kazuo Shibuta, Yoshiyuki Tsuboi, Barry John Sessle, Yoshiki Imamura, Koichi Iwata · 2013 · Journal of Neuroscience
6. Pathogenic Mutations Differentially Regulate Cell-to-Cell Transmission of α-Synuclein
   Yuan Guan, Xiaofang Zhao, Fengwei Liu, Shuxin Yan, Yalong Wang, Cuilian Du, Xiuyu Cui, Rena Li, Claire Xi Zhang · 2020 · Frontiers in Cellular Neuroscience
7. α-Synuclein enhances secretion and toxicity of amyloid beta peptides in PC12 cells
   Anna Wilkaniec, Joanna Benigna Strosznajder, Agata Adamczyk · 2008 · Neurochemistry International
8. Proteomic analysis of microglial contribution to mouse strain-dependent dopaminergic neurotoxicity
   McLaughlin, Patrick, Zhou, Yong, Ma, Tracy, Liu, Jun, Zhang, Wei, Hong, Jau‐Shyong, Kovacs, Monika, Zhang, Jing · 2006 · Glia
9. Complement cascade functions during brain development and neurodegeneration
   Oluwaseun Fatoba, Takahide Itokazu, Toshihide Yamashita · 2021 · FEBS Journal
10. Biological Potential, Gastrointestinal Digestion, Absorption, and Bioavailability of Algae-Derived Compounds with Neuroprotective Activity: A Comprehensive Review
    Bruna Martins, Mónica Vieira, Cristina Maria Delerue-Matos, Clara Grosso, Cristina Maria Dias Soares · 2022 · Marine Drugs
11. Protein Transmission, Seeding and Degradation: Key Steps for α-Synuclein Prion-Like Propagation
    Abid Oueslati, Methodios Ximerakis, Kostas Vekrellis · 2014 · Experimental Neurobiology
12. Immunotherapy Targeting α-Synuclein, with Relevance for Future Treatment of Parkinson‘s Disease and Other Lewy Body Disorders
    Veronica Lindström, Elisabet Ihse, Therese Fagerqvist, Joakim J. E. Bergström, Eva K. L. Nordström, Christer Möller, Lars Lannfelt, Martin Ingelsson · 2014 · Immunotherapy
13. α-Synuclein-containing erythrocytic extracellular vesicles: essential contributors to hyperactivation of monocytes in Parkinson’s disease
    Zongran Liu, Robin Chan, Zhijian Cai, Xiaodan Liu, Yufeng Wu, Zhenwei Yu, Tao Feng, Ying Yang, Jing Zhang · 2022 · Journal of Neuroinflammation
14. Inflammatory pre-conditioning restricts the seeded induction of α-synuclein pathology in wild type mice
    Emily J. Koller, Mieu Brooks, Todd Eliot Golde, Benoit I. Giasson, Paramita Chakrabarty · 2017 · Molecular Neurodegeneration
15. Concise Review: Modeling Neurodegenerative Diseases with Human Pluripotent Stem Cell-Derived Microglia
    Walther Haenseler, Lawrence Rajendran · 2019 · Stem Cells
16. Telomere shortening leads to an acceleration of synucleinopathy and impaired microglia response in a genetic mouse model
    Scheffold, Annika, Holtman, Inge R., Dieni, Sandra, Brouwer, Nieske, Katz, Sarah-Fee, Jebaraj, Billy Michael Chelliah, Kahle, Philipp J., Hengerer, Bastian, Lechel, André, Stilgenbauer, Stephan et al. · 2016 · Acta Neuropathologica Communications
17. Activated microglia facilitate the transmission of α-synuclein in Parkinson's disease
    Tingting Zheng, Zhengxiang Zhang · 2021 · Neurochemistry International
18. Synaptic Dysfunction in Multiple Sclerosis: A Red Thread from Inflammation to Network Disconnection
    Laura Bellingacci, Andrea Mancini, Lorenzo Gaetani, Alessandro Tozzi, Lucilla Parnetti, Massimiliano Di Filippo · 2021 · International Journal of Molecular Sciences
19. Human neuromelanin an endogenous microglial activator for dopaminergic neuron death
    Wei Zhang · 2012 · Frontiers in Bioscience-Elite
20. Inflammatory Mediators as Biomarkers in Brain Disorders
    Domenico Nuzzo, Pasquale Picone, Luca Caruana, Sonya Vasto, Annalisa Barera, Calogero Caruso, Marta Di Carlo · 2013 · Inflammation
21. Intravital correlated microscopy reveals differential macrophage and microglial dynamics during resolution of neuroinflammation
    Tjakko J. van Ham, Colleen A. Brady, Ruby D. Kalicharan, Nynke Oosterhof, Jeroen Kuipers, Anneke Veenstra-Algra, Klaas A. Sjollema, Randall Theodore Peterson, Harm H. Kampinga, Ben N. G. Giepmans · 2014 · Disease Models & Mechanisms
22. Systems Approach to Neurodegenerative Disease Biomarker Discovery
    Christopher G. Lausted, Inyoul Lee, Yong Feng Zhou, Shizhen Qin, Jaeyun Sung, Nathan D. Price, Leroy Hood, Kai Wang · 2013 · The Annual Review of Pharmacology and Toxicology
23. Innate immunity and cellular senescence: The good and the bad in the developmental and aged brain
    Santoro, Antonietta, Spinelli, Chiara Carmela, Martucciello, Stefania, Nori, Stefania Lucia, Capunzo, Mario, Puca, Annibale Alessandro, Ciaglia, Elena · 2018 · Journal of Leukocyte Biology
24. Brain clearance of protein aggregates: a close-up on astrocytes
    Veronica Giusti, Gurkirat Kaur, Elena Giusto, Laura Civiero · 2024 · Molecular Neurodegeneration
25. Identification of the amino acid sequence motif of α-synuclein responsible for macrophage activation
    Saet-byul Lee, Sang Myun Park, Keun Jae Ahn, Kwang Chul Chung, Seung R. Paik, Jongsun Kim · 2009 · Biochemical and Biophysical Research Communications
26. Neurons and Glia Interplay in α-Synucleinopathies
    Panagiota Mavroeidi, Maria Xilouri · 2021 · International Journal of Molecular Sciences
27. Association of Glial Activation and α-Synuclein Pathology in Parkinson’s Disease
    Rui Wang, Haigang Ren, Elena V. Kaznacheyeva, Xiaojun Lu, Guanghui Wang · 2022 · Neuroscience Bulletin
28. Neurodegenerative Disorders
    Talene A. Yacoubian · 2016 · Elsevier eBooks
29. The potential convergence of NLRP3 inflammasome, potassium, and dopamine mechanisms in Parkinson’s disease
    Adrianne F. Pike, Ildikò Szabó, Robert Veerhuis, Luigi Bubacco · 2022 · npj Parkinson s Disease
30. Do PPAR-Gamma Agonists Have a Future in Parkinson's Disease Therapy?
    Anna Rosa Carta, Augusta Pisanu, Ezio Carboni · 2011 · Parkinson s Disease
31. α-Mangostin Inhibits α-Synuclein-Induced Microglial Neuroinflammation and Neurotoxicity
    Zhaoyang Hu, Wei Wang, Ling Jing, Chunming Jiang · 2016 · Cellular and Molecular Neurobiology
32. Parkin deficiency exacerbate ethanol-induced dopaminergic neurodegeneration by P38 pathway dependent inhibition of autophagy and mitochondrial function
    Chul Ju Hwang, Young‐Eun Kim, Dong Ju Son, Mi Hee Park, Dong‐Young Choi, Pil‐Hoon Park, Mats Hellström, Sang‐Bae Han, Ki‐Wan Oh, Eunkyung Park et al. · 2016 · Redox Biology
33. Alpha-synuclein induces microglial migration via PKM2-dependent glycolysis
    Hongfei Qiao, Xijing He, Qiaojun Zhang, Haifeng Yuan, Dong Wang, Libo Li, Yanping Hui, Zhonghen Wu, Wenjuan Li, Ni Zhang · 2019 · International Journal of Biological Macromolecules
34. Activation of innate immunity by lysozyme fibrils is critically dependent on cross-β sheet structure
    Adelin Gustot, Vincent Raussens, Morgane Dehousse, Mireille Dumoulin, Clare Elizabeth Bryant, Jean‐Marie Ruysschaert, Caroline Lonez · 2013 · Cellular and Molecular Life Sciences
35. Role of Microglia in Age-Related Changes to the Nervous System
    David R. Brown · 2009 · The Scientific World JOURNAL
36. α‐synuclein‐induced mitochondrial dysfunction in isolated preparation and intact cells: Implications in the pathogenesis of Parkinson's disease
    Aritri Bir, Oishimaya Sen, Shruti Anand, Vineet Kumar Khemka, Priyanjalee Banerjee, Roberto Cappai, Arghyadip Sahoo, Sasanka Chakrabarti · 2014 · Journal of Neurochemistry
37. Astrocytic CCAAT/Enhancer-binding protein delta contributes to reactive oxygen species formation in neuroinflammation
    Shao‐Ming Wang, Sher-Wei Lim, Ya-Han Wang, Hong-Yi Lin, Ming-Derg Lai, Chiung‐Yuan Ko, Ju‐Ming Wang · 2018 · Redox Biology
38. Human Microglial Cells Undergo Proapoptotic Induction and Inflammatory Activation upon in vitro Exposure to a Naturally Occurring Level of Aflatoxin B1
    Jalil Mehrzad, Saman Hosseinkhani, Amir Mohammad Malvandi · 2018 · NeuroImmunoModulation
39. Lack of Alpha-Synuclein Modulates Microglial Phenotype In Vitro
    Susan A. Austin, Lalida Rojanathammanee, Mikhail Y. Golovko, Eric J. Murphy, Colin Kelly Combs · 2011 · Neurochemical Research
40. Novel protective properties of auranofin: Inhibition of human astrocyte cytotoxic secretions and direct neuroprotection
    JocelynM Madeira, Colby Renschler, B. Mueller, Sadayuki Hashioka, Deanna Lynn Gibson, Andis Klegeris · 2013 · Life Sciences
41. TGF-β1 mediates hypoxia-preconditioned olfactory mucosa mesenchymal stem cells improved neural functional recovery in Parkinson’s disease models and patients
    Yi Zhuo, Wenshui Li, Wen Quan Lu, Xuan Li, Lite Ge, Yan Huang, Qingtao Gao, Yu-Jia Deng, Xinchen Jiang, Zi-Wei Lan et al. · 2024 · Military Medical Research
42. Microglial dynamics and neuroinflammation in prodromal and early Parkinson’s disease
    Frida Lind‐Holm Mogensen, Philip Seibler, Anne Grünewald, Alessandro Michelucci · 2025 · Journal of Neuroinflammation
43. RETRACTED: Inhibition of Rho‐kinase by Fasudil protects dopamine neurons and attenuates inflammatory response in an intranasal lipopolysaccharide‐mediated Parkinson's model
    He, Qing, Li, Yan‐hua, Guo, Si‐si, Wang, Ying, Lin, Wei, Zhang, Qiong, Wang, Jian, Ma, Cun‐gen, Xiao, Bao‐Guo · 2016 · European Journal of Neuroscience · Retracted
44. Autophagy Modulators and Neuroinflammation
    Kyoung Sang Cho, Jang Ho Lee, Jeiwon Cho, Guang‐Ho Cha, Gyun Jee Song · 2018 · Current Medicinal Chemistry
45. Therapeutic potential of mangiferin in the treatment of various neuropsychiatric and neurodegenerative disorders
    Walia, Vaibhav, Chaudhary, Sushil Kumar, Kumar Sethiya, Neeraj · 2021 · Neurochemistry International
46. Human serum albumin in neurodegeneration
    Sajjad Shojai, S. Rohani, Ali Akbar Moosavi‐Movahedi, Mehran Habibi-Rezaei · 2022 · Reviews in the Neurosciences
47. Human Apolipoprotein A-I Natural Variants: Molecular Mechanisms Underlying Amyloidogenic Propensity
    N. Ramella, G. Schinella, S. Ferreira, E. Prieto, M. Vela, J. Ríos, M. Tricerri, O. Rimoldi · 2012 · PLoS ONE
48. Photoexcited Toluidine Blue Inhibits Tau Aggregation in Alzheimer’s Disease
    Tushar Dubey, Nalini Vijay Gorantla, Kagepura Thammaiah Chandrashekara, Subashchandrabose Chinnathambi · 2019 · ACS Omega
49. Complex Interaction between Resident Microbiota and Misfolded Proteins: Role in Neuroinflammation and Neurodegeneration
    Juliana González-Sanmiguel, Christina Maria Anna Pia Schuh, Carola Muñoz-Montesino, Pamina Contreras‐Kallens, Luis Gerardo Aguayo, Sebastian D Aguayo · 2020 · Cells
50. The metabolite GLP‐1 (9‐36) is neuroprotective and anti‐inflammatory in cellular models of neurodegeneration
    Yazhou Li, Elliot J. Glotfelty, Tobias E. Karlsson, Lowella V. Fortuno, Brandon K. Harvey, Nigel H. Greig · 2021 · Journal of Neurochemistry
51. Extracellular Alpha-Synuclein: Mechanisms for Glial Cell Internalization and Activation
    Chavarría, Cecilia, Ivagnes, Rodrigo, Souza, José M. · 2022 · Biomolecules
52. Apocyanin, a Microglial NADPH Oxidase Inhibitor Prevents Dopaminergic Neuronal Degeneration in Lipopolysaccharide-Induced Parkinson’s Disease Model
    Neha Sharma, Bimla Nehru · 2015 · Molecular Neurobiology
53. α-Synuclein and its neurotoxic fragment inhibit dopamine uptake into rat striatal synaptosomes
    Agata Adamczyk, Anna Wilkaniec, Joanna Benigna Strosznajder · 2006 · Neurochemistry International
54. Alpha-synuclein, autophagy-lysosomal pathway, and Lewy bodies: Mutations, propagation, aggregation, and the formation of inclusions
    Armin Bayati, Peter Scottt McPherson · 2024 · Journal of Biological Chemistry
55. Involvement of dopaminergic neuronal cystatin C in neuronal injury‐induced microglial activation and neurotoxicity
    Garima Dutta, David S. Barber, Ping Zhang, Nicholas J. Doperalski, Bin Liu · 2012 · Journal of Neurochemistry
56. Inhibitory effect of ginsenoside Rg1 on lipopolysaccharide-induced microglial activation in mice
    Jinfeng Hu, Xiu‐Yun Song, Shifeng Chu, Ji Chen, Haijie Ji, Xiaoyu Chen, Yu‐He Yuan, Ning Han, Juntian Zhang, Nai‐Hong Chen · 2010 · Brain Research
57. Differential Proteome of the Striatum from Hemiparkinsonian Rats Displays Vivid Structural Remodeling Processes
    Grit Lessner, Oliver Schmitt, Stefan Jean-Pierre Haas, Stefan Mikkat, Michael Kreutzer, Andreas Wree, Michael O. Glocker · 2010 · Journal of Proteome Research
58. Alpha-Synuclein and Microglia in Parkinson’s Disease: From Pathogenesis to Therapeutic Prospects
    Hyemi Eo, Sehwan Kim, Un Ju Jung, Sang Ryong Kim · 2024 · Journal of Clinical Medicine
59. Hypoestoxide reduces neuroinflammation and α-synuclein accumulation in a mouse model of Parkinson’s disease
    Kim, Changyoun, Ojo-Amaize, Emmanuel, Spencer, Brian, Rockenstein, Edward, Mante, Michael, Desplats, Paula, Wrasidlo, Wolf, Adame, Anthony, Nchekwube, Emeka, Oyemade, Olusola et al. · 2015 · Journal of Neuroinflammation
60. Lycopodium Attenuates Loss of Dopaminergic Neurons by Suppressing Oxidative Stress and Neuroinflammation in a Rat Model of Parkinson’s Disease
    Richard L. Jayaraj, Rami Beiram, Sheikh Azimullah, Mohamed Fizur Nagoor Meeran, Shreesh Kumar Ojha, Abdu Adem, Fakhreya Yousuf Jalal · 2019 · Molecules
61. Prionoid Proteins in the Pathogenesis of Neurodegenerative Diseases
    Cameron Wells, Samuel E. Brennan, Matthew Keon, Nitin Saksena · 2019 · Frontiers in Molecular Neuroscience
62. Fyn Kinase Activity and Its Role in Neurodegenerative Disease Pathology: a Potential Universal Target?
    Bianca Guglietti, Srisankavi Sivasankar, Sanam Mustafa, Frances Corrigan, Lyndsey E. Collins‐Praino · 2021 · Molecular Neurobiology
63. The complex role of inflammation and gliotransmitters in Parkinson's disease
    Adithya Gopinath, Phillip M. Mackie, Leah T. Phan, Malú G. Tansey, Habibeh Khoshbouei · 2022 · Neurobiology of Disease
64. Assembly of Lysine 63-linked Ubiquitin Conjugates by Phosphorylated α-Synuclein Implies Lewy Body Biogenesis
    Chao Liu, Erkang Fei, Nali Jia, Hongfeng Wang, Rui-Song Tao, Atsushi Iwata, Nobuyuki Nukina, Jiang‐Ning Zhou, Guanghui Wang · 2007 · Journal of Biological Chemistry
65. Mass Spectrometry-Based Analysis of Serum N-Glycosylation Changes in Patients with Parkinson’s Disease
    Mingming Xu, Hong Jin, Zhen Wu, Ying Han, Jing Chen, Chengjie Mao, Piliang Hao, Xumin Zhang, Chun‐Feng Liu, Shuang Yang · 2022 · ACS Chemical Neuroscience
66. Acute and Chronic 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Administrations Elicit Similar Microglial Activation in the Substantia Nigra of Monkeys
    Marianne Vázquez‐Claverie, Pablo Garrido‐Gil, Waldy San Sebastián, Amaya Izal‐Azcárate, Silvia Belzunegui, Irene Marcilla, Berta López, M. R. Luquín · 2009 · Journal of Neuropathology & Experimental Neurology
67. α-Synuclein in Parkinson's Disease: Pathogenic Function and Translation into Animal Models
    Judith Eschbach, Karin M. Danzer · 2013 · Neurodegenerative Diseases
68. Future directions for immune modulation in neurodegenerative disorders: focus on Parkinson’s disease
    Kathleen A. Maguire‐Zeiss, Howard J. Federoff · 2010 · Journal of Neural Transmission
69. Altered Expression Patterns of Inflammation-Associated and Trophic Molecules in Substantia Nigra and Striatum Brain Samples from Parkinson's Disease, Incidental Lewy Body Disease and Normal Control Cases
    Douglas G. Walker, Lih‐Fen Lue, Geidy E. Serrano, Charles H. Adler, John N. Caviness, Lucia I. Sue, Thomas G. Beach · 2016 · Frontiers in Neuroscience
70. Extracellular α-synuclein drives sphingosine 1-phosphate receptor subtype 1 out of lipid rafts, leading to impaired inhibitory G-protein signaling
    Shaymaa Mohamed Mohamed Badawy, Taro Okada, Taketoshi Kajimoto, Mitsuhiro Hirase, Shubi Ambwene Matovelo, Shunsuke Nakamura, Daisuke Yoshida, Takeshi Ijuin, Shun‐ichi Nakamura · 2018 · Journal of Biological Chemistry
71. Aquaporin 4: A key player in Parkinson's disease
    Omid Reza Tamtaji, Mohammad Behnam, Mohammad Ali Pourattar, Hamed Jafarpour, Zatollah Asemi · 2019 · Journal of Cellular Physiology
72. Omega-3 Fatty Acids as Druggable Therapeutics for Neurodegenerative Disorders
    Neha Milind Chitre, Nader H. Moniri, Kevin Sean Murnane · 2019 · CNS & Neurological Disorders - Drug Targets
73. Commentary: Progressive inflammation as a contributing factor to early development of Parkinson's disease
    Suraj Pradhan, Katrin I. Andreasson · 2012 · Experimental Neurology
74. Screening of Toll-Like Receptors Expression in Multiple System Atrophy Brains
    Brudek, Tomasz, Winge, Kristian, Agander, Tina Klitmøller, Pakkenberg, Bente · 2013 · Neurochemical Research
75. Synaptotagmin‐11 inhibits cytokine secretion and phagocytosis in microglia
    Cuilian Du, Yalong Wang, Feifan Zhang, Shuxin Yan, Yuan Guan, Xiaoli Gong, Ting Zhang, Xiuyu Cui, Xiaomin Wang, Claire Xi Zhang · 2017 · Glia
76. Suppression of NLRP3 Inflammasome, Pyroptosis, and Cell Death by NIM811 in Rotenone-Exposed Cells as an in vitro Model of Parkinson’s Disease
    Minghao Zhang, Qingping He, Guisheng Chen, P. Andy Li · 2020 · Neurodegenerative Diseases
77. Alpha-synuclein Immunization Strategies for Synucleinopathies in Clinical Studies: A Biological Perspective
    Luisa Harriet Knecht, Jonas Folke, Richard C. Dodel, Jean Alexander Ross, Alexandra Albus · 2022 · Neurotherapeutics
78. Gold drug auranofin could reduce neuroinflammation by inhibiting microglia cytotoxic secretions and primed respiratory burst
    Jocelyn M. Madeira, Ekta Bajwa, Maegan Stuart, Sadayuki Hashioka, Andis Klegeris · 2014 · Journal of Neuroimmunology
79. Neurovascular Unit in Chronic Pain
    Beatrice Mihaela Radu, Placido Bramanti, Francesco Osculati, Maria‐Luiza Flonta, Mihai Radu, Giuseppe Bertini, Paolo Francesco Fabene · 2013 · Mediators of Inflammation
80. α-Synuclein: A therapeutic target for Parkinson’s disease?
    Kathleen A. Maguire‐Zeiss · 2008 · Pharmacological Research
81. Transmission of Synucleinopathies in the Enteric Nervous System of A53T Alpha-Synuclein Transgenic Mice
    He-Jin Lee, Ji‐Eun Suk, Kyung-Won Lee, Seung-Hwa Park, Peter Charles Blumbergs, Wei‐Ping Gai, Seung‐Jae Lee · 2011 · Experimental Neurobiology
82. The degeneration and replacement of dopamine cells in Parkinson’s disease: the role of aging
    Manuel Rodrı́guez, Ingrid Moráles, Clara Rodriguez‐Sabate, Alberto Sánchez, Rafael Castro, José Miguel Brito Armas, Magdalena Sabaté · 2014 · Frontiers in Neuroanatomy
83. Early fine motor impairment and behavioral dysfunction in (Thy‐1)‐h[A30P] alpha‐synuclein mice
    Sara Ekmark‐Lewén, Veronica Lindström, Astrid Gumucio, Elisabeth Ihse, Anish Behere, Philipp J. Kahle, Eva K. L. Nordström, Maria Eriksson, Anna Erlandsson, Joakim J. E. Bergström et al. · 2018 · Brain and Behavior
84. Translation Imaging in Parkinson’s Disease: Focus on Neuroinflammation
    S. Belloli, M. Morari, Valentina Murtaj, S. Valtorta, R. Moresco, M. Gilardi · 2020 · Frontiers in Aging Neuroscience
85. Sequential and cellular detection of copper and lactic acid by disaggregation and reaggregation of the fluorescent panchromatic fibres of an acylthiourea based sensor
    Vivekshinh Kshtriya, Bharti Koshti, Deepak K. Pandey, Sumit Kharbanda, Chandra Kanth P., Dheeraj Kumar Singh, Dhiraj Devidas Bhatia, Nidhi Gour · 2021 · Soft Matter
86. Neurodegeneration and peroxidases
    Johannes Everse, Penelope W. Coates · 2007 · Neurobiology of Aging
87. The α-synuclein burden hypothesis of Parkinson disease and its relationship to Alzheimer disease
    McGeer, Patrick L., McGeer, Edith G. · 2008 · Experimental Neurology
88. Molecular changes in the absence of severe pathology in the pulvinar in dementia with Lewy bodies
    Erskine, Daniel, Ding, Jinhui, Thomas, Alan J., Kaganovich, Alice, Khundakar, Ahmad A., Hanson, Peter S., Taylor, John‐Paul, McKeith, Ian G., Attems, Johannes, Cookson, Mark R. et al. · 2018 · Movement Disorders
89. The BSSG rat model of Parkinson’s disease: progressing towards a valid, predictive model of disease
    Jackalina M. Van Kampen, H.A. Robertson · 2017 · The EPMA Journal
90. MicroRNA-7 Protects Against Neurodegeneration Induced by α-Synuclein Preformed Fibrils in the Mouse Brain
    Jie Zhang, Mengyuan Zhao, Run Yan, Jun Liu, Santhosh Chandar Maddila, Eunsung Junn, M. Maral Mouradian · 2021 · Neurotherapeutics
91. Predominant Release of Lysosomal Enzymes by Newborn Rat Microglia After LPS Treatment Revealed by Proteomic Studies
    Jun Liu, Zhen Hong, Jianqing Ding, Jianrong Liu, Jing Zhang, Shengdi Chen · 2008 · Journal of Proteome Research
92. The Biochemical and Cellular Basis for Nutraceutical Strategies to Attenuate Neurodegeneration in Parkinson’s Disease
    ELIZABETH A. MAZZIO, Fran T. Close, Karam F. A. Soliman · 2011 · International Journal of Molecular Sciences
93. Involvement of Endocytosis and Alternative Splicing in the Formation of the Pathological Process in the Early Stages of Parkinson’s Disease
    Anelya Kh. Alieva, Maria I. Shadrina, Elena V. Filatova, Aleksey V. Karabanov, Sergey Nikolaevich Illarioshkin, Svetlana A. Limborska, Petr A. Slominsky · 2014 · BioMed Research International
94. Genetic Imaging of Neuroinflammation in Parkinson’s Disease: Recent Advancements
    Longping Yao, Jiayu Wu, Sümeyye Koç, Guohui Lu · 2021 · Frontiers in Cell and Developmental Biology
95. Contribution of Autophagy-Lysosomal Pathway in the Exosomal Secretion of Alpha-Synuclein and Its Impact in the Progression of Parkinson’s Disease
    Denisse Sepúlveda, Marisol Cisternas-Olmedo, Javiera Arcos, Melissa Nassif, René L. Vidal · 2022 · Frontiers in Molecular Neuroscience
96. The cervical lymph node contributes to peripheral inflammation related to Parkinson’s disease
    Zongran Liu, Yang Huang, Xue-Jing Wang, Jia-Yi Li, Can Zhang, Ying Yang, Jing Zhang · 2023 · Journal of Neuroinflammation
97. Kynurenines in Parkinson’s disease: therapeutic perspectives
    Dénes Zádori, Péter Klivènyi, József Toldi, Ferenc Fülöp, László Vécsei · 2011 · Journal of Neural Transmission
98. Squamosamide derivative FLZ protects dopaminergic neurons against inflammation-mediated neurodegeneration through the inhibition of NADPH oxidase activity
    Dan Zhang, Xiaoming Hu, Sung‐Jen Wei, Jie Liu, Hui‐Ming Gao, Qian Li, Belinda C. Wilson, Geng-Tao Liu, Jau‐Shyong Hong · 2008 · Journal of Neuroinflammation
99. A window into the brain: Tools to assess pre-clinical efficacy of biomaterials-based therapies on central nervous system disorders
    Juhi Samal, Ana Lúcia Rebelo, Abhay S. Pandit · 2019 · Advanced Drug Delivery Reviews
100. A cullin-RING ubiquitin ligase targets exogenous α-synuclein and inhibits Lewy body–like pathology
     Juan Gerez, Natalia Cecilia Prymaczok, Edward M. Rockenstein, U. Herrmann, Petra Schwarz, Anthony Adame, Radoslav Ivanov Enchev, Thibault Courthéoux, Paul J. Boersema, Roland Riek et al. · 2019 · Science Translational Medicine